Treatment of Refractory Cardiac Arrest by Controlled Reperfusion of the Whole Body: A Multicenter, Prospective Observational Study
- PMID: 38202063
- PMCID: PMC10780178
- DOI: 10.3390/jcm13010056
Treatment of Refractory Cardiac Arrest by Controlled Reperfusion of the Whole Body: A Multicenter, Prospective Observational Study
Abstract
Background: Survival following cardiac arrest (CA) remains poor after conventional cardiopulmonary resuscitation (CCPR) (6-26%), and the outcomes after extracorporeal cardiopulmonary resuscitation (ECPR) are often inconsistent. Poor survival is a consequence of CA, low-flow states during CCPR, multi-organ injury, insufficient monitoring, and delayed treatment of the causative condition. We developed a new strategy to address these issues. Methods: This all-comers, multicenter, prospective observational study (69 patients with in- and out-of-hospital CA (IHCA and OHCA) after prolonged refractory CCPR) focused on extracorporeal cardiopulmonary support, comprehensive monitoring, multi-organ repair, and the potential for out-of-hospital cannulation and treatment. Result: The overall survival rate at hospital discharge was 42.0%, and a favorable neurological outcome (CPC 1+2) at 90 days was achieved for 79.3% of survivors (CPC 1+2 survival 33%). IHCA survival was very favorable (51.7%), as was CPC 1+2 survival at 90 days (41%). Survival of OHCA patients was 35% and CPC 1+2 survival at 90 days was 28%. The subgroup of OHCA patients with pre-hospital cannulation showed a superior survival rate of 57.1%. Conclusions: This new strategy focusing on repairing damage to multiple organs appears to improve outcomes after CA, and these findings should provide a sound basis for further research in this area.
Keywords: cardiac arrest; cardiopulmonary resuscitation; extracorporeal cardiopulmonary resuscitation; extracorporeal circulation; organ repair.
Conflict of interest statement
The authors declare the following competing interests. G.T. is a shareholder of and consultant at Resuscitec GmbH. C.B. is a part-time employee and shareholder of Resuscitec GmbH. C.S., J.S.P., and S.J.B. are part-time employees of Resuscitec GmbH. F.B. is a founder and shareholder of Resuscitec GmbH, a start-up company of the University Hospital Freiburg, Germany. H.A., D.D.R.M., and E.T. received speaker honoraria from Resuscitec GmbH. The remaining authors declare no conflicts of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.
Figures


References
-
- Reynolds J.C., Grunau B.E., Elmer J., Rittenberger J.C., Sawyer K.N., Kurz M.C., Singer B., Proudfoot A., Callaway C.W. Prevalence, natural history, and time-dependent outcomes of a multi-center North American cohort of out-of-hospital cardiac arrest extracorporeal CPR candidates. Resuscitation. 2017;117:24–31. doi: 10.1016/j.resuscitation.2017.05.024. - DOI - PubMed
-
- Virani S.S., Alonso A., Benjamin E.J., Bittencourt M.S., Callaway C.W., Carson A.P., Chamberlain A.M., Chang A.R., Cheng S., Delling F.N., et al. Heart Disease and Stroke Statistics-2020 Update: A Report From the American Heart Association. Circulation. 2020;141:e139–e596. doi: 10.1161/CIR.0000000000000757. - DOI - PubMed
-
- Yan S., Gan Y., Jiang N., Wang R., Chen Y., Luo Z., Zong Q., Chen S., Lv C. The global survival rate among adult out-of-hospital cardiac arrest patients who received cardiopulmonary resuscitation: A systematic review and meta-analysis. Crit. Care. 2020;24:61. doi: 10.1186/s13054-020-2773-2. - DOI - PMC - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Medical